Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

Loke, Yoon K.; Singh, Sonal; Furberg, Curt D.
January 2009
CMAJ: Canadian Medical Association Journal;1/6/2009, Vol. 180 Issue 1, p32
Academic Journal
Background: Rosiglitazone and pioglitazone may increase the incidence of fractures. We aimed to determine systematically the risk of fractures associated with thiazolidinedione therapy and to evaluate the effect of the therapy on bone density. Methods: We searched MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), other trial registries and product information sheets through June 2008. We selected long-term (⩾ 1 year) randomized controlled trials involving patients with type 2 diabetes and controlled observational studies that described the risk of fractures or changes in bone density with thiazolidinediones. We calculated pooled odds ratios (ORs) for fractures and the weighted mean difference in bone density. Results: We analyzed data from 10 randomized controlled trials involving 13 715 participants and from 2 observational studies involving 31 679 participants. Rosiglitazone and pioglitazone were associated with a significantly increased risk of fractures overall in the 10 randomized controlled trials (OR 1.45, 95% confidence interval [CI] 1.18-1.79; p < 0.001). Five randomized controlled trials showed a significantly increased risk of fractures among women (OR 2.23, 95% CI 1.65-3.01; p < 0.001) but not among men (OR 1.00, 95% CI 0.73-1.39; p = 0.98). The 2 observational studies demonstrated an increased risk of fractures associated with rosiglitazone and pioglitazone. Bone mineral density in women exposed to thiazolidinediones was significantly reduced at the lumbar spine (weighted mean difference -1.11%, 95% CI -2.08% to -0.14%; p = 0.02) and hip (weighted mean difference -1.24%, 95%CI -2.34% to -0.67%; p < 0.001) in 2 randomized controlled trials. Interpretation: Long-term thiazolidinedione use doubles the risk of fractures among women with type 2 diabetes, without a significant increase in risk of fractures among men with type 2 diabetes.


Related Articles

  • Impact of Walking on Glycemic Control and Other Cardiovascular Risk Factors in Type 2 Diabetes: A Meta-Analysis. Qiu, Shanhu; Cai, Xue; Schumann, Uwe; Velders, Martina; Sun, Zilin; Steinacker, Jürgen Michael // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Background: Walking is the most popular and most preferred exercise among type 2 diabetes patients, yet compelling evidence regarding its beneficial effects on cardiovascular risk factors is still lacking. The aim of this meta-analysis of randomized controlled trials (RCTs) was to evaluate the...

  • Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials. Fang, Yanfu; Hu, Chuanlai; Tao, Xingyong; Wan, Yuhui; Tao, Fangbiao // Journal of Bone & Mineral Metabolism;Jan2012, Vol. 30 Issue 1, p60 

    A number of randomized controlled trials (RCTs) examining the role of vitamin K on bone mineral density (BMD) have yielded inconsistent results. We performed a meta-analysis of these trials to assess the effect of vitamin K on BMD. We searched MEDLINE, EMBASE and CENTRAL for relevant studies of...

  • Review: bariatric surgery reduces weight and improves type 2 diabetes in adults.  // Evidence Based Medicine;Oct2009, Vol. 14 Issue 5, p6 

    The article examines the efficacy of bariatric surgery in reducing the weight and improve type 2 diabetes in adult patients. Through meta-analysis in a randomized controlled trials, researchers found out bariatric surgery led to weight loss to patients with type 2 diabetes. It could also lower...

  • Effects of lifestyle education program for type 2 diabetes patients in clinics: a cluster randomized controlled trial. Misa Adachi; Kazue Yamaoka; Mariko Watanabe; Masako Nishikawa; Itsuro Kobayashi; Eisuke Hida; Toshiro Tango // BMC Public Health;2013, Vol. 13 Issue 1, p1 

    Background: The prevalence of type 2 diabetes is rising worldwide, as has been the global mean fasting plasma glucose level. This study aimed to evaluate the effectiveness of a structured individual-based lifestyle education (SILE) program to reduce the hemoglobin A1c (HbA1c) level in type 2...

  • A portion-control plate was effective for weight loss in obese patients with type 2 diabetes mellitus.  // ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p68 

    The article offers information on a clinical study investigating the effectiveness of portion-control (PC) plate, for weight loss in the obese type 2 diabetes mellitus patients. It discusses the methods followed along with the randomized controlled trials carried out during the study. It...

  • Inhaled insulin plus glargine may be alternative to standard therapy. Brannon, Matthew; Kalvaitis, Katie; Southall, Jennifer // Endocrine Today;Jul2010, Vol. 8 Issue 7, p14 

    The article discusses the results of an open-label, randomized trial which investigated the effectiveness of premeal inhaled insulin plus insulin glargine before bedtime at controlling glucose in patients with type 2 diabetes.

  • Reducing the stigma of mental illness in undergraduate medical education: a randomized controlled trial. Andriyka Papish; Kassam, Aliya; Modgill, Geeta; Vaz, Gina; Zanussi, Lauren; Patten, Scott // BMC Medical Education;2013, Vol. 13 Issue 1, p1 

    Background The stigma of mental illness among medical students is a prevalent concern that has far reaching negative consequences. Attempts to combat this stigma through educational initiatives have had mixed results. This study examined the impact of a one-time contact based educational...

  • Short-Term Effects of an Educational Program on Health-Seeking Behavior for Infections in Patients With Type 2 Diabetes. Venmans, Leonie M. A. J.; Gorter, Kees J.; Hak, Eelko; Rutten, Guy E. H. M. // Diabetes Care;Mar2008, Vol. 31 Issue 3, p402 

    OBJECTIVE -- The aim of this study was to assess the short-term effects of an educational program on (determinants of) self-reported health-seeking behavior for infections of the urinary tract (UTIs) and lower respiratory tract (LRTIs) in patients with type 2 diabetes. RESEARCH DESIGN AND...

  • A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers. Wilding, John P.H.; Norwood, Paul; T'Joen, Caroline; Bastien, Arnaud; List, James F.; Fiedorek, Fred T. // Diabetes Care;Sep2009, Vol. 32 Issue 9, p1656 

    OBJECTIVE -- To determine whether dapagliflozin, which selectively inhibits renal glucose reabsorption, lowers hyperglycemia in patients with type 2 diabetes that is poorly controlled with high insulin doses plus oral antidiabetic agents (OADs). RESEARCH DESIGN AND METHODS -- This was a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics